Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSkillcast Regulatory News (SKL)

Share Price Information for Skillcast (SKL)

Share Price is delayed by 15 minutes
Get Live Data
46.00    0.00 (0.00%)
Bid:
45.00
Ask:
47.00
Spread: 2.00 (4.444%)
Market Cap: £41.27m
SKL Live PriceLast checked at - London Stock Exchange

Intraday Skillcast Share Chart

Exercise of Share Options and Total Voting Rights

26 May 2026 16:52

RNS Number : 7643F
Skillcast Group PLC
26 May 2026
 

Skillcast Group plc

("Skillcast", the "Group", or the "Company")

Exercise of Share Options and Total Voting Rights

 

Skillcast Group plc (AIM: SKL), the provider of SaaS compliance software and off-the-shelf e-learning, announces that it has issued and allotted a total of 122,500 new ordinary shares of £0.001 each in the capital of the Company ("Ordinary Shares") following the exercise of options by employees of the Company.

Application has been made to the London Stock Exchange for the 122,500 new Ordinary Shares to be admitted to trading on AIM ("Admission") and it is expected that Admission will become effective, and trading will commence at 8.00 a.m. on 29 May 2026.

Total Voting Rights

After Admission, the total number of Ordinary Shares in issue will be 89,721,960 and the total number of voting rights will therefore be 89,721,960. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

For further information, please contact:

Skillcast Group plc

+44 (0)20 7929 5000

Richard Amos, Chairman

Vivek Dodd, Chief Executive Officer

Richard Steele, Chief Financial Officer

Cavendish (Nominated Adviser & Broker)

+44 (0)20 7220 0500

Jonny Franklin-Adams / Isaac Hooper (Corporate Finance)

Sunila de Silva (Corporate broking)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRPPURCAUPQGAQ
12
Date   Source Headline
23rd Jun 202611:53 amRNSResult of AGM
10th Jun 20262:10 pmRNSDirector Dealings
28th May 202610:54 amRNSGrant of share options
28th May 20267:00 amRNSNotice of AGM and dividend declaration
26th May 20264:52 pmRNSExercise of Share Options and Total Voting Rights
29th Apr 202612:12 pmRNSFinal Results - Replacement
29th Apr 20267:00 amRNSFinal Results
22nd Apr 20267:00 amRNSNotice of Results & Investor Presentation via IMC
28th Jan 20267:00 amRNSFull Year Trading Update
8th Jan 202611:06 amRNSExercise of Share Options and Total Voting Rights
31st Oct 20252:09 pmRNSGrant of share options
29th Oct 20251:26 pmRNS-RYellowstone Advisory and Mello Events
22nd Sep 20254:19 pmRNSMello Results Special Presentation
19th Sep 202511:28 amRNSInvestor Presentation via Investor Meet Company
19th Sep 20257:00 amRNSResults for the six months ended 30 June 2025
23rd Jul 20257:00 amRNSTrading Update and Notice of Interim Results
26th Jun 20257:00 amRNSAppointment of Nominated Adviser and Sole Broker
24th Jun 202512:00 pmRNSResult of AGM
23rd May 202512:30 pmRNS-RInvestor Event - Mello 2025
23rd May 20257:00 amRNSNotice of AGM and Dividend Declaration
30th Apr 20257:00 amRNSFinal Results
24th Apr 20257:00 amRNSNotice of Results and Investor Presentation
30th Jan 202510:24 amRNSGrant of share options
23rd Jan 20257:00 amRNSFull Year Trading Update
18th Sep 20247:00 amRNSResults for the six months ended 30 June 2024
25th Jul 20247:00 amRNSTrading Update and Notice of Interim Results
25th Jun 20243:18 pmRNSResult of AGM
24th Jun 20247:00 amRNSDirectorate Change
30th May 20244:43 pmRNSNotice of AGM
25th Apr 20247:00 amRNSResults for the 12 months ended 31 December 2023
17th Apr 202412:22 pmRNSNotice of Results and Investor Presentation
31st Jan 20247:00 amRNSFull Year Trading Update
21st Nov 20237:00 amRNSInvestor presentation
7th Nov 20233:00 pmRNSDirector Declaration
27th Sep 20237:00 amRNSInterim Results
18th Sep 20237:00 amRNSNotice of Investor Presentation
19th Jul 20237:00 amRNSTrading Update and Notice of Interim Results
20th Jun 20233:45 pmRNSResult of AGM
23rd May 20233:07 pmRNSDividend declaration and Notice of AGM
11th May 20237:00 amRNSGrant of share options
26th Apr 20237:00 amRNSFinal Results
20th Apr 20237:00 amRNSNotice of Results and Investor Presentation
27th Feb 20232:27 pmRNSDirector/PDMR Shareholding
27th Jan 20233:02 pmRNSDirector/PDMR Shareholding
26th Jan 20237:00 amRNSFull Year Trading Update
8th Nov 20227:00 amRNSInvestor presentation
28th Sep 202210:26 amRNSInvestor Presentation
28th Sep 20227:00 amRNSInterim Results
27th Jul 20227:00 amRNSTrading Update and Notice of Interim Results
23rd Jun 20227:00 amRNSGrant of share options
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.